27330995|t|A comparative analysis of lncRNAs in prostate cancer exosomes and their parental cell lines
27330995|a|Prostate cancer is the second leading cancer in men world - wide. Due to its heterogeneous nature, a considerable amount of research effort has been dedicated in identifying effective clinical biomarkers with a focus on proteins, messenger RNA and microRNAs [1]. However, there is limited data on the role and expression of long noncoding RNAs (lncRNAs) in prostate cancer exosomes [2]. This array dataset which is linked to our publication describes the profiling of human lncRNAs in prostate cancer and their exosomes from five different cell lines [3]. From this dataset, we identified a list of statistically significant prostate cancer lncRNAs which are differentially expressed in the exosomes compared to their parent cell lines. This dataset has been deposited into Gene Expression Omnibus (GSE81034).
27330995	2	22	comparative analysis	T062	C0683941
27330995	26	33	lncRNAs	T114	C2982391
27330995	37	52	prostate cancer	T191	C0600139
27330995	53	61	exosomes	T026	C2350332
27330995	72	80	parental	T080	C0205556
27330995	81	91	cell lines	T025	C0007600
27330995	92	107	Prostate cancer	T191	C0600139
27330995	115	121	second	T081	C0205436
27330995	122	129	leading	T169	C1522538
27330995	130	136	cancer	T191	C0007097
27330995	140	143	men	T098	C0025266
27330995	144	149	world	T098	C2700280
27330995	152	156	wide	T082	C0332464
27330995	158	164	Due to	T169	C0678226
27330995	169	182	heterogeneous	T080	C0019409
27330995	183	189	nature	T078	C0349590
27330995	206	212	amount	T081	C1265611
27330995	216	224	research	T062	C0035168
27330995	225	231	effort	T040	C0015264
27330995	254	265	identifying	T080	C0205396
27330995	266	275	effective	T080	C1704419
27330995	276	284	clinical	T080	C0205210
27330995	285	295	biomarkers	T201	C0005516
27330995	303	308	focus	T169	C1285542
27330995	312	320	proteins	T116,T123	C0033684
27330995	322	335	messenger RNA	T114,T123	C0035696
27330995	340	349	microRNAs	T114,T123	C1101610
27330995	373	380	limited	T169	C0439801
27330995	381	385	data	T078	C1511726
27330995	393	397	role	T077	C1705810
27330995	402	412	expression	T045	C0017262
27330995	416	435	long noncoding RNAs	T114	C2982391
27330995	437	444	lncRNAs	T114	C2982391
27330995	449	464	prostate cancer	T191	C0600139
27330995	465	473	exosomes	T026	C2350332
27330995	484	489	array	T082	C1510941
27330995	490	497	dataset	T170	C0150098
27330995	521	532	publication	T073,T170	C0034036
27330995	547	556	profiling	T169	C2003903
27330995	560	565	human	T016	C0086418
27330995	566	573	lncRNAs	T114	C2982391
27330995	577	592	prostate cancer	T191	C0600139
27330995	603	611	exosomes	T026	C2350332
27330995	622	631	different	T080	C1705242
27330995	632	642	cell lines	T025	C0007600
27330995	658	665	dataset	T170	C0150098
27330995	670	680	identified	T080	C0205396
27330995	691	716	statistically significant	T081	C0237881
27330995	717	732	prostate cancer	T191	C0600139
27330995	733	740	lncRNAs	T114	C2982391
27330995	751	765	differentially	T080	C0443199
27330995	766	775	expressed	T045	C0017262
27330995	783	791	exosomes	T026	C2350332
27330995	792	800	compared	T052	C1707455
27330995	817	827	cell lines	T025	C0007600
27330995	834	841	dataset	T170	C0150098
27330995	851	860	deposited	T169	C0333562
27330995	866	889	Gene Expression Omnibus	T170	C0150098